​

Theravance Biopharma Ownership | Who Owns Theravance Biopharma?

OverviewForecastRevenueFinancialsChartTranscripts

Theravance Biopharma Ownership Summary

Theravance Biopharma is owned by 93.40% institutional investors, 4.45% insiders, and 2.15% retail investors. Madison avenue partners, lp is the largest institutional shareholder, holding 19.40% of TBPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.26% of its assets in Theravance Biopharma shares.

TBPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTheravance Biopharma93.40%4.45%2.15%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Madison avenue partners, lp9.51M19.40%$89.50M
Weiss asset management lp7.46M15.00%$82.25M
Newtyn management4.95M9.96%$54.60M
Blackrock funding, inc. /de4.14M8.33%$45.65M
Blackrock3.78M7.83%$32.06M
Irenic capital management lp2.76M5.55%$30.45M
Vanguard group2.01M4.10%$18.92M
Park west asset management1.80M3.62%$19.84M
State street1.27M2.62%$10.75M
Oasis management1.12M2.25%$12.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Madison avenue partners, lp9.51M9.48%$89.50M
Newtyn management4.95M8.27%$54.60M
Irenic capital management lp2.76M4.49%$30.45M
Park west asset management1.80M1.50%$19.84M
Oasis management1.12M1.41%$12.34M
Weiss asset management lp7.46M0.95%$82.25M
Camber capital management lp450.00K0.47%$4.96M
Militia capital partners, lp54.20K0.28%$597.83K
Corton capital33.35K0.18%$313.79K
Virtus investment advisers41.88K0.16%$461.98K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de4.14M0.00%687.70K
Jefferies financial group276.89K0.03%255.46K
Newtyn management4.95M8.27%192.60K
Ubs group174.25K0.00%143.49K
Acadian asset management308.65K0.01%134.06K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---4.20M
Pictet asset management sa---684.89K
Camber capital management lp450.00K0.47%-550.00K
Blackrock3.78M0.00%-428.18K
Arrowstreet capital, limited partnership---221.47K

New Positions

HolderShares% AssetsChangeValue
Capitolis liquid global markets127.20K0.01%127.20K$1.40M
Jump financial79.07K0.01%79.07K$872.19K
Connor, clark & lunn investment management56.61K0.00%56.61K$624.44K
Militia capital partners, lp54.20K0.28%54.20K$597.83K
Campbell & co investment adviser50.39K0.04%50.39K$555.82K

Sold Out

HolderChange
True wealth design-3.00
Capital performance advisors llp-5.00
Nelson, van denburg & campbell wealth management group-13.00
Lindbrook capital-14.00
Corecap advisors-27.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251352.27%46,426,0143.43%931.15%7732.76%32-31.91%
Mar 31, 20251333.10%44,910,1350.05%901.08%59-10.61%4845.45%
Dec 31, 202446-61.98%6,919,684-84.88%140.16%23-56.60%11-73.17%
Sep 30, 2024121-9.02%45,773,807-2.84%931.00%53-22.06%41-8.89%
Jun 30, 20241329.09%47,111,010-1.79%970.99%6828.30%44-4.35%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.14M2.26%-25.24K
Vanguard US Total Market Shares ETF1.07M2.15%-
iShares Russell 2000 ETF903.11K1.81%-17.11K
Pictet Biopharmaceutical Mother652.30K1.32%-349.81K
Vanguard Institutional Extnd Mkt Idx Tr388.76K0.77%-167.02K
Fidelity Small Cap Index375.01K0.75%-
iShares Russell 2000 Value ETF336.22K0.67%-
State St Russell Sm/Mid Cp® Indx NL Cl C330.21K0.66%958.00
State St Russell Sm/Mid Cp® Indx SL Cl I330.21K0.66%-
CREF Stock R1308.81K0.62%-

Recent Insider Transactions

DateNameRoleActivityValue
Jul 14, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$7.77K
Jul 14, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$60.55K
Jul 14, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$45.55K
Jun 02, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$264.00K
Apr 21, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$36.00K

Insider Transactions Trends

DateBuySell
2025 Q3-3
2025 Q2-2
2025 Q1-1
2024 Q4-1
2024 Q3-1

TBPH Ownership FAQ

Who Owns Theravance Biopharma?

Theravance Biopharma shareholders are primarily institutional investors at 93.40%, followed by 4.45% insiders and 2.15% retail investors. The average institutional ownership in Theravance Biopharma's industry, Biotech Stocks , is 304.14%, which Theravance Biopharma falls below.

Who owns the most shares of Theravance Biopharma?

Theravance Biopharma’s largest shareholders are Madison avenue partners, lp (9.51M shares, 19.40%), Weiss asset management lp (7.46M shares, 15.00%), and Newtyn management (4.95M shares, 9.96%). Together, they hold 44.36% of Theravance Biopharma’s total shares outstanding.

Does Blackrock own Theravance Biopharma?

Yes, BlackRock owns 7.83% of Theravance Biopharma, totaling 3.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.06M$. In the last quarter, BlackRock decreased its holdings by -428K shares, a -10.17% change.

Who is Theravance Biopharma’s biggest shareholder by percentage of total assets invested?

Madison avenue partners, lp is Theravance Biopharma’s biggest shareholder by percentage of total assets invested, with 9.48% of its assets in 9.51M Theravance Biopharma shares, valued at 89.5M$.

Who is the top mutual fund holder of Theravance Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Theravance Biopharma shares, with 2.26% of its total shares outstanding invested in 1.14M Theravance Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools